Prne
September 24th, 2009
CALGARY, Canada - Resverlogix Corp. (TSX:RVX) announced today that it will host a live teleconference and webcast on Tuesday, September 29, 2009 at 1:00 pm Eastern/11:00 am Mountain time. The purpose of the teleconference is to discuss the top line results of the Company’s Phase 1b/2a clinical trial for RVX-208, an oral small molecule in development to treat atherosclerosis and cardiovascular disease.
The dial-in numbers for this event are toll free 1-800-319-4610 and international 1-604-638-5340. A link for this webcast will be posted onto the homepage of Resverlogix’s website and can be accessed from the following address services.choruscall.com/links/resverlogix090928.html.
The webcast will be available on the Resverlogix website for replay for a period of 45 days after the event.
About Resverlogix Corp.
Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) PR program is the Company’s primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as Acute Coronary Syndrome, Diabetes, Alzheimer’s disease, Peripheral Artery Disease and other vascular disorders. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit www.resverlogix.com.
This news release may contain certain forward-looking statements that reflect the current views and/or expectations of Resverlogix Corp. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. The TSX Exchange does not accept responsibility for the adequacy or accuracy of this news release.
For further information: Theresa Kennedy, VP, Corporate Communications, Resverlogix Corp., Phone: +1-604-538-7072, Fax: +1-403-256-8495, Email: Theresa@resverlogix.com; US Investor Relations: Susan Noonan, Managing Partner, S.A. Noonan Communications, LLC, Phone: +1-212+966-3650, Email: susan@sanoonan.com; US Media Relations: Eric Goldman, Vice President, Rx Communications Group, Phone: +1-917-322-2563, Email: egoldman@rxir.com
Source: Resverlogix Corp.
For further information: Theresa Kennedy, VP, Corporate Communications,
Resverlogix Corp., Phone: +1-604-538-7072, Fax: +1-403-256-8495, Email:
Theresa at resverlogix.com; US Investor Relations: Susan Noonan, Managing
Partner, S.A. Noonan Communications, LLC, Phone: +1-212+966-3650, Email:
susan at sanoonan.com; US Media Relations: Eric Goldman, Vice President, Rx
Communications Group, Phone: +1-917-322-2563, Email: egoldman at rxir.com
Filed under Biotechnology, Business, Clinical Trials / Medical Discoveries, Conference Call Announcements, Health, Health Care / Hospitals, Pharmaceuticals | Tags: Calgary, canada, Resverlogix Corp. | Comment Below
Related Press Releases Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport MarkersSeptember 28th, 2009 CALGARY, Canada -
- Powerful Effects Seen in all Subjects Including Those With Low HDL - Representing a Majority of Myocardial Infarct Patients
TSX Exchange Symbol: RVX
Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Banco Santander Chile Analyst and Investor Conference Call / WebcastJuly 28th, 2009 SANTIAGO, Chile -
- Time: 10:00 a.m. (EDT) July 31, 2009
You are cordially invited to participate in Banco Santander Chile's (NYSE: SAN) conference call/webcast on Friday, July 31, 2009, 10:00 a.m. Magna International Inc. - Notice of Conference Call for Second Quarter 2009 ResultsJuly 23rd, 2009 AURORA, Canada - Magna International Inc. (TSX: MG.A; NYSE: MGA) will release its financial results for the second quarter ended June 30, 2009, on Friday, August 7, 2009. Hudson Highland Group Schedules Conference Call and Webcast to Discuss Second Quarter Financial ResultsJuly 13th, 2009 NEW YORK -
Hudson Highland Group, Inc. (Nasdaq: HHGP), one of the world's leading providers of permanent recruitment, contract professionals and talent management solutions, will issue its second quarter financial results for the period ended June 30, 2009 after the market closes on Wednesday, July 29, 2009. FEMSA Schedules Conference Call to Discuss Second Quarter 2009 Financial ResultsJuly 8th, 2009 MONTERREY, Mexico -
Fomento Economico Mexicano, S.A.B. de C.V. ("FEMSA") (NYSE: FMX; BMV: FEMSAUBD) is pleased to invite you to participate in its Second Quarter 2009 Conference Call that will be held on:
Tuesday, July 28, 2009 11:00 AM Eastern Time (10:00 AM Mexico City Time)
Javier Astaburuaga, Chief Financial Officer of FEMSA, will host the call and discuss FEMSA's 2nd quarter 2009 financial results, followed by a question and answer session. Magna International Inc. - Annual Meeting of Shareholders and Notice of Conference Call for First Quarter 2009 ResultsApril 27th, 2009 AURORA, Canada - Magna International Inc. (TSX: MG.A; NYSE: MGA) is holding its Annual Meeting of Shareholders on Wednesday, May 6, 2009 at the Hilton Suites Toronto/Markham Conference Centre, 8500 Warden Avenue, Markham, Ontario, Canada commencing at 10:00 a.m. Banco Santander Chile Announces Time Change for Its Analyst and Investor Conference Call-WebcastApril 26th, 2009 SANTIAGO, Chile - New time: 11:00 a.m. (EDT) April 30, 2009
Banco Santander Chile's (NYSE: SAN) conference call-webcast will now begin at 11:00 a.m. Banco Santander Chile Analyst and Investor Conference Call-WebcastApril 20th, 2009 SANTIAGO, Chile - 10:00 a.m. (EDT), April 30, 2009
You are cordially invited to participate in Banco Santander Chile's (NYSE: SAN) conference call-webcast on Thursday, April 30, 2009, where we will discuss 1Q 2009 financial results. Royal Caribbean to Hold Conference Call on First Quarter ResultsApril 13th, 2009 MIAMI - Royal Caribbean Cruises Ltd. (NYSE: RCL; Oslo) has scheduled a conference call for 10 a.m. FEMSA Schedules Conference Call to Discuss First Quarter 2009 Financial ResultsApril 12th, 2009 MONTERREY, Mexico - Fomento Economico Mexicano, S.A.B. de C.V. ("FEMSA") (NYSE: FMX; BMV: FEMSAUBD) is pleased to invite you to participate in its First Quarter 2009 Conference Call that will be held on:
Thursday, April 30, 2009 11:00 AM Eastern Time (10:00 AM Mexico City Time)
Javier Astaburuaga, Chief Financial Officer of FEMSA, will host the call and discuss FEMSA's 1st quarter 2009 financial results, followed by a question and answer session.
Related News GVK Biosciences forms clinical research alliance with Excel PharmaStudiesApril 14th, 2009 HYDERABAD - GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Excel PharmaStudies (Excel), a leading Chinese Clinical Research Organization announced a strategic alliance to conduct clinical trials in Asia. The alliance provides clinical trial sponsors access to the scientific skills, talent pool, flexible resourcing, and cost-effectiveness of both India and China. MakroCare announces workshop on Advanced GCP on May 15May 6th, 2009 HYDERABAD - MakroCare, a global clinical services firm, provides clinical research support to pharmaceutical, biotechnology, and medical device industries, is taking a lead in the training of professionals for the clinical research industry by providing series of informational through workshop and seminars. Advanced GCP workshop will be held at CHITRAMAYEE Auditorium, State Arts Gallery, Kavuri Hills, Madhapur, Hyderabad on May 15. Fast acting erectile disorder drug goes on trial againFebruary 15th, 2009 WASHINGTON - A new fast-acting oral drug for erectile dysfunction (ED) is ready for a crucial trial phase. It's going to be a multicentre, randomised, double-blind, placebo-controlled trial that will evaluate the safety and efficacy of Avanafil in the treatment of ED in men with type-1 or type-2 diabetes. Indian clinical research company to set-up unit in Kuala LumpurJuly 27th, 2009 NEW DELHI - The Ahmedabad-based Veeda Clinical Research organization is entering Malaysia's medical sector by setting up its advanced research unit at the Ampang Hospital in Kuala Lumpur by the year-end. India's fastest-growing clinical research organisation has selected the Ampang Hospital to conduct first phase clinical trials on humans under a quasi-commercial agreement with the Malaysian Health Ministry, The Star Online reports. US says settlement in principle in UBS tax evasion case; judge in Fla. cancels Monday trialJuly 31st, 2009 Settlement near in UBS tax evasion caseMIAMI — A federal judge is Florida is canceling a planned trial for Swiss bank UBS after the Swiss and U.S. governments struck a deal over allegations that Americans hid money overseas. Venezuela says Interpol has issued 'red notice' for Chavez foeApril 24th, 2009 Venezuela: Interpol issues notice for Chavez foeCARACAS, Venezuela — Interpol has issued a notice seeking the arrest of a leading opponent of Venezuelan President Hugo Chavez who has requested political asylum in Peru, a Venezuelan police chief said Thursday. Federal police chief Wilmer Flores said Interpol sent out a "red notice" for Manuel Rosales, the former mayor of Venezuela's second-largest city, Maracaibo, who faces embezzlement charges in his homeland. Merck's heart failure drug rolofylline misses main and backup goals in late-stage trialJune 5th, 2009 Merck's heart failure drug misses trial goalsWHITEHOUSE STATION, N.J. — Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo. Apex court asked to restore notice for QuattrocchiApril 28th, 2009 NEW DELHI - A lawyer Tuesday urged the Supreme Court to check the authenticity of media reports that the government had withdrawn the red corner notice against Ottavio Quatrocchi, fugitive in a number of cases related to the Bofors scandal. In his petition, lawyer Ajay Agarwal asked the apex court to issue directions to the central government to restore the red corner notice in case it has been withdrawn. World Tamil Conference in Coimbatore next JanuarySeptember 19th, 2009 CHENNAI - The ninth World Tamil Conference will be held in the textile city of Coimbatore Jan 21-24 next year, Tamil Nadu Chief Minister M. Karunanidhi said here Saturday. The high street face cream that even scientists say can banish wrinklesApril 28th, 2009 LONDON - Women's prayers have finally been answered - scientists have confirmed that a bestselling face cream available on the high street can visibly reduce wrinkles. What's more, the miraculous lotion can reduce the damage caused by the sun.
|
|
